.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Mesopancreas excision has emerged as a vital step in pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). Consequently, medical professionals seek to understand its impact on long-term survival. A clinical study recently analyzed mesopancreas excision recurrence patterns among 86 patients treated at a tertiary care center. The results offer significant insights into the surgical and oncological outcomes of this radical technique.
Furthermore, researchers reported that the surgical team achieved R0 resection in 73 patients, representing a high success rate of 84.9%. However, high surgical precision did not prevent recurrence in many cases. Specifically, 60.5% of patients developed recurrent disease within a median of 11.3 months. Additionally, the study noted that distant metastases occurred more frequently than isolated local failures.
In contrast to traditional theories, local recurrence only accounted for 34.6% of the recurrent cases. Moreover, the liver became the most common site for distant spread, followed by the lungs and the peritoneum. Statistical modeling further identified several independent predictors. Lymph node positivity, poor tumor differentiation, and elevated CA19-9 levels significantly increased the risk of disease return. Consequently, these high-risk patients may require more intensive postoperative monitoring.
Therefore, while complete mesopancreas excision improves the quality of local surgery, PDAC remains a systemic challenge. Clinicians should consider early systemic therapy to address potential micrometastases. Furthermore, prospective randomized trials are still necessary to confirm the long-term superiority of this technique over standard procedures.
The technique aims to clear the retroperitoneal margin more effectively, which often leads to higher R0 resection rates. Consequently, it may reduce local recurrence, although distant metastasis remains a significant risk for most patients.
Elevated CA19-9 levels and lymph node involvement are the strongest predictors of recurrence after surgery. Additionally, tumors that show poor differentiation tend to behave more aggressively and recur earlier.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Saleh SK et al. Mesopancreas excision in pancreatic ductal adenocarcinoma: recurrence patterns - a single-arm descriptive study. World J Surg Oncol. 2026 Jun 22. doi: 10.1186/s12957-026-04459-4. PMID: 42324571.
Gaedcke J et al. The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg. 2010;395(4):451-8.
Popescu I, Dumitrascu T. What is the Value of Total Mesopancreas Excision in Pancreatic Ductal Adenocarcinoma? Current Evidence of the Literature. Chirurgia (Bucur). 2012;107(4):437-44.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This study evaluates 86 PDAC patients following mesopancreas excision. While surgeons achieved R0 resection in 84.9% of cases, 60.5% experienced recurrence, primarily as distant metastases in the liver. Key predictors of recurrence included lymph node positivity, poor differentiation, and elevated CA19-9.
4 months ago
Depemokimab offers twice-yearly dosing for severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps, significantly cutting exacerbations and hospital admissions.
3 days back
A novel copper metal-organic framework hydrogel remodels the uterine microenvironment to stimulate robust endometrial regeneration, reduce intrauterine fibrosis, and restore reproductive fertility, offering a groundbreaking strategy for managing refractory endometrial damage and Asherman syndrome.
3 days back
New research reveals that non-ablative radiotherapy suppresses ventricular tachycardia by increasing conduction velocity via NaV1.5 upregulation and action potential prolongation. However, sustained sodium current elevation and depressed calcium handling highlight the need for careful clinical translation.
5 days back
A single-cell transcriptomic atlas reveals how peripheral nerve injuries cause dorsal root ganglion remodeling. By evaluating proximal nerve crush and resection, researchers identify distinct glial and immune programs that resolve neuropathic pain and promote regeneration.
3 days back
A breakthrough study demonstrates that fullerol-primed extracellular vesicles generated in a 3D SECCS bioreactor attenuate ferroptosis and restore myogenic regeneration in diabetes via the FOXO3 pathway, offering a cell-free therapeutic strategy for diabetic musculoskeletal degeneration.
3 days back
